Cargando…
In vitro characterization of CT‐001—a short‐acting factor VIIa with enhanced prohemostatic activity
BACKGROUND: Traumatic injury and the associated acute bleeding are leading causes of death in people aged 1 to 44 years. Acute bleeding in pathological and surgical settings also represents a significant burden to the society. Yet there are no approved hemostatic drugs currently available. While cli...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265787/ https://www.ncbi.nlm.nih.gov/pubmed/34263099 http://dx.doi.org/10.1002/rth2.12530 |